Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-17

FDA Approved: TEZSPIRE — Original Application (Amgen Inc)

View source ↗

Summary

The FDA approved Tezspire (tezepelumab-ekko) from Amgen under an original Biologics License Application. It is indicated for severe, uncontrolled asthma in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tezspire (tezepelumab)

Snippet

ORIG AP for TEZSPIRE (TEZEPELUMAB-EKKO)